BIOMAT Database Logo BIOMAT Database Logo

Differential hemodynamic effects of oral enoximone in severe congestive heart failure. 1990

S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Division of Cardiology, Presbyterian-University Hospital, Pittsburgh, Pennsylvania 15213.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
August 1987, The American journal of cardiology,
S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Hemodynamic effects of prolonged intravenous therapy with enoximone in patients with severe congestive heart failure.
January 1988, Journal of cardiovascular pharmacology,
S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
January 1981, Circulation,
S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
July 1986, The American journal of cardiology,
S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Oral enoximone pharmacokinetics in patients with congestive heart failure.
September 1987, Journal of clinical pharmacology,
S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure.
April 1984, Journal of the American College of Cardiology,
S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
May 1988, American heart journal,
S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Hemodynamic effects of oral nicorandil in congestive heart failure.
June 1990, The American journal of cardiology,
S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Deleterious hemodynamic effects of lidocaine in severe congestive heart failure.
September 1989, American heart journal,
S Murali, and B F Uretsky, and A R Betschart, and T R Tokarczyk, and J A Kolesar, and P S Reddy
Comparative hemodynamic effects of intravenous digoxin and enoximone in severe chronic heart failure.
January 1994, Cardiology,
Copied contents to your clipboard!